Nicolai Tangen
AKO Capital
AKO Capital Portfolio 13F
Nicolai Tangen Holdings Activity
- Portfolio value:
- $7.14B≈ (-$2B≈)
- Previous value:
- $9.26B≈
- # of changes:
- 25
- New positions:
- 0
- Reported for:
- 30 Jun 2022 (Q2)
- Latest filing date:
- 09 Aug 2022
AKO Capital has disclosed a total of 25 changes to the portfolio in the (2022 Q2) SEC report(s): increased the number of shares of 14 and decreased the number of shares of 11 position(s).
What stocks did Nicolai Tangen buy in 2022 Q2?
During 2022 Q2 Nicolai Tangen has bought 14 securities out of which top 5 purchases (by % change to portfolio) were (TMO) Thermo Fisher Scientific Inc (added shares +0.49%), (ACN) Accenture plc (added shares +0.34%), (V) Visa Inc, CL-A (added shares +84.42%), (EFX) Equifax Inc (added shares +8.02%) and (ICE) Intercontinental Exchange Inc (added shares +12.22%).
In the 2022 Q2 report(s) the following changes have been made to the top investments: (TMO) Thermo Fisher Scientific Inc (added shares +0.49%), (ACN) Accenture plc (added shares +0.34%), (BKNG) Booking Holdings Inc (reduced shares -10.88%), (V) Visa Inc, CL-A (added shares +84.42%) and (EFX) Equifax Inc (added shares +8.02%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.